1439 related articles for article (PubMed ID: 25687629)
1. The epidemiology of inflammatory bowel disease.
Burisch J; Munkholm P
Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
[TBL] [Abstract][Full Text] [Related]
2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
3. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
5. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
[TBL] [Abstract][Full Text] [Related]
6. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
[TBL] [Abstract][Full Text] [Related]
7. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
8. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
9. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
[TBL] [Abstract][Full Text] [Related]
11. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
[TBL] [Abstract][Full Text] [Related]
14. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
[TBL] [Abstract][Full Text] [Related]
15. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
18. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
19. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
